GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cian Healthcare Ltd (BOM:542678) » Definitions » Research & Development

Cian Healthcare (BOM:542678) Research & Development : ₹0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cian Healthcare Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Cian Healthcare's Research & Development for the six months ended in Mar. 2024 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.0 Mil.

Cian Healthcare Research & Development Historical Data

The historical data trend for Cian Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cian Healthcare Research & Development Chart

Cian Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.01 - - - -

Cian Healthcare Semi-Annual Data
Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cian Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cian Healthcare  (BOM:542678) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cian Healthcare Research & Development Related Terms

Thank you for viewing the detailed overview of Cian Healthcare's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Cian Healthcare (BOM:542678) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cian Healthcare Ltd (BOM:542678) » Definitions » Research & Development
Comparable Companies
BOM:537253 NSE:JFLLIFE BOM:524703 BOM:530057 BOM:542248 BOM:543963 BOM:524711 BOM:530317 BOM:506919 NSE:WALPAR ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Vitthal Rao Shivarkar Road, Office No. 508-511, 5th Floor, Sacred World, Above Macdonald, Wanowrie, Pune, MH, IND, 411040
Website
https://www.cian.co
Cian Healthcare Ltd is a fully integrated pharmaceutical company. It is engaged in the research, development, and manufacturing of different forms of tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets. The company's portfolio comprises of gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotics, CNS, vitamins, and nutrient products. It operates in five sectors namely Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party. The majority of the revenue is generated from the Indian Market.

Cian Healthcare (BOM:542678) Headlines

No Headlines